公开(公告)号：US11180471B2

公开(公告)日：2021-11-23

申请号：US16535120

申请日：2019-08-08

申请人： Bayer Pharma Aktiengesellschaft

发明人： Eloisa Jimenez Nunez ,  Jens Ackerstaff ,  Susanne Roehrig ,  Alexander Hillisch ,  Katharina Meier ,  Stefan Heitmeier ,  Adrian Tersteegen ,  Jan Stampfuss ,  Pascal Ellerbrock ,  Daniel Meibom ,  Dieter Lang

IPC分类号： A61K31/4439 ,  A61P7/02 ,  C07D401/10 ,  C07D401/14 ,  C07D413/14 ,  C07D413/10

摘要： The invention relates to substituted oxopyridine derivatives and to processes for their preparation, and also to their use for preparing medicaments for the treatment and/or prophylaxis of diseases, in particular cardiovascular disorders, preferably thrombotic or thromboembolic disorders, and oedemas, and also ophthalmic disorders.